Clinical trials
Colonic Neoplasms trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
118 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 3 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 7 |
| 2018 | 3 |
| 2019 | 12 |
| 2020 | 10 |
| 2021 | 7 |
| 2022 | 14 |
| 2023 | 11 |
| 2024 | 4 |
| 2025 | 9 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 46 |
| Recruiting | 24 |
| Unknown status | 21 |
| Active, not recruiting | 13 |
| Terminated | 8 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 2 |
| Approved for marketing | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 7 |
| Novartis Pharmaceuticals | 6 |
| Corporacion Parc Tauli | 5 |
| Pfizer | 5 |
| GlaxoSmithKline | 4 |
| City of Hope Medical Center | 3 |
| Universidad Complutense de Madrid | 3 |
| AbbVie | 2 |
| Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | 2 |
| Grupo Hospital de Madrid | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colonic Neoplasms | 118 |
| Colorectal Neoplasms | 44 |
| Rectal Neoplasms | 33 |
| Neoplasms | 19 |
| Breast Neoplasms | 17 |
| Lung Neoplasms | 16 |
| Carcinoma, Non-Small-Cell Lung | 15 |
| Neoplasm Metastasis | 15 |
| Endometrial Neoplasms | 8 |
| Intestinal Neoplasms | 8 |
Trials
Showing 26 to 50 of 118. Each trial links to its page on Pharma Observatory.
18 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.